Attention Raises $14 Million to Augment all Sales Functions with AI-powered Automations

NEW YORK, Oct. 24, 2024Attention, the platform that transforms customer conversations into actionable insights, announced today its $14 million Series A funding to power its next phase of growth. The investment was led by Alven, with participation from Eniac, 645 Ventures, Aglae, Frst, and Liquid2. The funding highlights the growing demand for Attention’s AI product and solutions as the business saw a 10x revenue increase this year, with customers including Crunchbase, BambooHR, Aircall, and Clay amongst others.

Founded by repeat entrepreneurs and former competitors, Anis Bennaceur and Matthias Wickenburg, Attention addresses a critical need in the market: enabling revenue teams to unlock and utilize the valuable data hidden in customer interactions. Traditional methods of capturing and analyzing this data are expensive, error-prone, and incomplete. Attention automates this process, offering sales teams a powerful tool to close more deals using the voice of the customer.

“Automating CRM entry out of customer conversations and writing follow-up emails was just the beginning. There is so much more to do out of these precious interactions,” said Bennaceur, Co-Founder and CEO of Attention.

Attention will use the new funding to fulfill strong market demand and expand its go-to-market team, while continuing to invest in product and engineering to solidify its leadership in the AI-driven sales market – a category it pioneered.Attention’s long-term vision is ambitious: to fully automate the routine tasks handled by revenue and sales teams, enabling them to focus on more strategic activities.

“We have built a system of cognition that continuously learns and improves, delivering better results over time,” said Wickenburg, Co-Founder and CTO of Attention. “We believe that our technology will not only enhance jobs but also redefine them, making sales teams more efficient and effective than ever.”

Thomas Cuvelier, General Partner at lead investor Alven, who has also backed transformative AI unicorns such as Dataiku and Algolia, added: “Attention’s Generative AI native capabilities are a paradigm shift to a system of cognition for the revenue function – they can effectively clone top performers by extracting features out of successful sales deals while at the same time dramatically enhance productivity. Anis and Matthias have an exceptional eye for product, and have built a compelling proposition in what is a very large, fast-growing, and dynamic market.”

Austin Myers, VP Revenue at Certificial and Attention customer shared, “Thanks to Attention, our sales pipeline velocity has skyrocketed. With automated CRM entry and insightful scorecards, deals progress smoothly, leading to quicker conversions. It’s streamlined our processes and turbocharged our revenue growth.”

This round of funding marks a pivotal chapter in Attention’s growth story. With a robust foundation, a clear strategic direction, and the support of world-class investors, the company is poised to make significant strides in revolutionizing sales enablement for businesses worldwide.

To get in touch with the Attention team, reach out at [email protected].

About Attention

Attention is a leading AI-powered platform dedicated to helping sales and revenue teams unlock the full potential of their customer conversations. By automating the extraction of actionable insights, Attention enables businesses to make informed decisions, enhance performance, and drive growth.

About Alven

Alven is an early-stage venture capital firm investing in world-class teams and products, and guiding entrepreneurs from seed to growth across the US and Europe. With over $2 billion under management, Alven has backed over 180 teams in the last two decades, including many success stories such as Stripe, Algolia, Dataiku, Qonto and Gorgias.

Photo – https://mma.prnewswire.com/media/2538940/Attention__Anis_Bennaceur_CEO_and_Matthias_Wickenburg_CTO.jpg

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Planetary Technologies Secures $11.35 Million in Series A Funding to Accelerate Carbon Removal Initiatives

HALIFAX, NS, Oct. 24, 2024 – Planetary Technologies, a leader in ocean-based climate solutions, has completed its Series A funding round, raising $11.35 million USD.

Led by Evok Innovations, the round includes new investors BDC Capital, Amplify Capital, DNX Ventures, and Iconiq Capital. These funds will support Planetary’s mission to enhance the ocean’s natural ability to fight climate change through carbon removal and storage.

“We’re most excited by the strong alignment that these investors have with our mission,” said Mike Kelland, CEO of Planetary Technologies. “This round enables us to continue leading the way on responsible, science-led development of a critical climate technology. Together, we are building a foundation that will allow us to achieve our vision of protecting and restoring both the ocean and climate for generations.”

Scaling Planetary’s Vision to Protect the Oceans and the Climate

Planetary Technologies uses ocean alkalinity enhancement (OAE) to remove carbon dioxide from the atmosphere. Roughly 25% of CO₂ emissions dissolve into the ocean, increasing acidity. Planetary’s process restores coastal environments, helping the ocean remove carbon more efficiently. This method mimics natural processes that have regulated atmospheric CO₂ for millions of years.

The new funding will allow Planetary to expand pilot projects, scale operations, and further demonstrate the safety and effectiveness of its technology. The company will continue collaborating with local communities, academic institutions, and regulatory bodies to ensure its solutions are both scientifically sound and sustainable.

“Evok Innovations is pleased to support Planetary Technologies in their mission to combat climate change through ocean-based solutions,” says Jane Kearns, Partner at Evok Innovations. “Planetary’s approach, rooted in science and community engagement, represents a significant step toward enhancing marine remediation & natural carbon removal processes. Evok values the Planetary team’s commitment to innovation and collaboration with local stakeholders, researchers and academic institutions, and we are excited to support their continued growth. We anticipate meaningful advancements in the near future, both for the company’s core business, and for marine carbon removal as a broader industry that will benefit from Planetary’s work”.

About Planetary Technologies

Planetary Technologies is a climate technology company focused on removing carbon through ocean alkalinity enhancement. By enhancing the ocean’s natural ability to absorb and store carbon, Planetary offers scalable solutions to climate change

SOURCE Planetary Technologies

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Jade Biosciences Appoints Tom Frohlich as Chief Executive Officer and Hetal Kocinsky as Chief Medical Officer; Forms Board of Directors and Expands Financing to $95 Million

Mr. Frohlich, formerly Chief Operating Officer of Chinook Therapeutics, brings 20+ years of leadership experience; Dr. Kocinsky offers deep expertise in developing therapies for autoimmune and kidney diseases

Board of Directors, comprised of industry veterans in science, business, and strategy, will support the company’s growth

Expanded financing to accelerate clinical development of Jade’s novel therapies targeting autoimmune diseases with significant unmet need

VANCOUVER, BC and SAN FRANCISCO, Oct. 24, 2024Jade Biosciences, Inc. (“Jade”), a biotechnology company dedicated to developing best-in-class therapies for patients living with autoimmune diseases, today announced the appointment of Tom Frohlich as Chief Executive Officer (CEO) and Hetal Kocinsky, M.D., as Chief Medical Officer (CMO). The company also introduced its newly formed Board of Directors, marking a significant step in the company’s growth trajectory.

Jade has extended its financing, bringing the total raised to $95 million. The financing round adds Frazier Life Sciences and Versant Ventures to an investor syndicate that includes Fairmount, Venrock Healthcare Capital Partners, Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, and Braidwell LP.

Strategic Appointments to Lead Jade’s Next Growth Phase

Tom Frohlich, Chief Executive Officer

Mr. Frohlich, a biotech and pharma industry veteran, brings over 20 years of experience in company building, business strategy, and product development. Before joining Jade, he co-founded and served as Chief Operating Officer (COO) of Chinook Therapeutics, where he guided the company’s growth through to its $3.2 billion acquisition by Novartis in 2023. He also held leadership roles at Arbutus Biopharma, Johnson & Johnson, and Merck, managing key areas such as commercial strategy and business development.

“I am honored to join Jade Biosciences and lead this talented team through such an exciting time,” said Frohlich. “With a strong balance sheet, world-class investors, and an experienced leadership team, we are well-positioned to advance therapies that will transform patient care in autoimmune diseases.”

Hetal Kocinsky, M.D., Chief Medical Officer

Dr. Kocinsky brings deep expertise in drug development, having led clinical programs from early-stage research to regulatory approvals across multiple therapeutic areas. Most recently, she served as Vice President of Translational Medicine at Chinook and held leadership roles at Apellis and Achillion Pharmaceuticals. A board-certified pediatric nephrologist, she also spent time as an Assistant Professor at the Yale School of Medicine.

“I look forward to working alongside the team at Jade in our quest to deliver breakthrough therapies to patients in need,” said Dr. Kocinsky. “With my background in translational medicine and experience navigating complex clinical landscapes, I look forward to accelerating solutions that can redefine care for patients with autoimmune diseases.”

New Board of Directors Brings Industry Expertise and Strategic Insight

Jade’s newly formed Board of Directors is led by Board Chairman Eric Dobmeier, former President and CEO of Chinook Therapeutics, and brings together industry leaders with expertise across science, business operations, and corporate strategy. The board includes:

  • Chris Cain, Ph.D. – Director of Research, Fairmount Funds Management LLC
  • Eric Dobmeier – Board Chairman, Venture Partner, Samsara BioCapital
  • Tom Frohlich – CEO, Jade Biosciences
  • Tomas Kiselak – Managing Member, Fairmount Funds Management LLC
  • Lawrence Klein, Ph.D. – CEO of Oruka Therapeutics
  • Erin Lavelle – Former COO and CFO at Profound Bio, Eliem Therapeutics; additional leadership roles at Alder BioPharmaceuticals and Amgen

About Jade Biosciences

Jade Biosciences is developing transformative therapies with the goal of redefining the standard of care for autoimmune diseases. The company launched in July 2024 and has raised $95 million from a strong slate of investors: Fairmount, Venrock Healthcare Capital Partners, Deep Track Capital, Driehaus Capital Management, Franklin Templeton, RTW Investments, Braidwell LP, Frazier Life Sciences, and Versant Ventures. Jade’s portfolio was engineered by Paragon Therapeutics. For more information, visit JadeBiosciences.com and follow us on LinkedIn.

Media Contact

[email protected]

SOURCE Jade Biosciences

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Dash Bio Raises $6.5M In Seed Financing

Newly-unveiled startup to speed up biotech and drug development

NEWTON, Mass., Oct. 24, 2024 — Dash Bio, an innovator in tech-enabled services for drug development, announced today that it has raised $6.5M in seed financing. The round was led by Freestyle Capital, with participation from Swift Ventures, LifeX Ventures, and other private investors.

Despite tremendous innovation in biotech research over the past decade – from pioneering applications of AI to major breakthroughs in mRNA and CRISPR – drug development remains slow and expensive, with new drugs costing an average of $6.7 billion and taking 12 years to get from concept to launch. That lag is driven by manual processes and legacy systems, which dramatically reduce the efficiency of clinical development and the effectiveness of the industry overall.

“Development is broken in biotech today, and we all pay the price,” says Dave Johnson, CEO and co-founder of Dash Bio and former Chief Data & AI Officer at Moderna. “We founded Dash Bio to ensure that groundbreaking medicines reach those who need them — faster.”

Now out of stealth, Dash Bio takes a technology-first approach to developing critical services across the drug development lifecycle. The company is building new capabilities that leverage AI, robotics, and fully-integrated software to fundamentally reinvent the way drugs are brought to market. Their first capability is a highly-automated clinical bioanalysis lab that promises to deliver GLP-compliant services with unprecedented speed.

Dash Bio’s founding team draws from a deep well of knowledge in this space. Founders include Dave Johnson (CEO), former Chief Data & AI Officer at Moderna; Ander Tallett (COO), CEO and founder of DigitalRadius and an experienced executive with stints at Moderna and Science Exchange; and Ely Porter, CTO and co-founder of Rootpath, a pioneer in synthetic immunology and gene synthesis.

“With the advancements of AI and quantum among other technologies, we are seeing huge advancements in drug discovery and expect that only to continue, but feel that the path from discovery through development to make drugs patient ready is still very antiquated and untouched by technology. We knew this was the team to tackle that challenge and you rarely find a team as deep in both AI and bio as this founding team,” says Maria Palma, General Partner at Freestyle Capital.

“We’re living through a golden age of biotech and drug discovery, but the reality is that the process for getting a drug to market threatens to slow progress. Dash Bio promises a new era of faster clinical drug development that meets the moment,” notes Brett Wilson, General Partner at Swift Ventures.

About Dash Bio
Dash Bio is rebuilding drug development from the ground up by leveraging AI, robotics, and fully-integrated software to fundamentally reinvent the way drugs are brought to market. Learn more at dash.bio.

SOURCE Dash Bio

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Sociaaal Secures $4M from Braavo Capital to Fuel Gen Z App Growth and Expand their Portfolio

NEW YORK, Oct. 24, 2024 — Sociaaal, the fast-growing mobile app studio that specializes in building, buying, and publishing non-gaming apps for Gen Z, is pleased to announce it has secured $4 million in financing from Braavo Capital. The funding will be used to focus on expanding their publishing unit to further scale the business, acquire more apps, and enhance marketing for their existing portfolio.

Founded in 2022, Sociaaal has quickly become a market leader with a portfolio of 20 apps and over 34 million downloads. With a focus on rapid app development, data-driven strategies, and refined user acquisition capabilities, Sociaaal successfully launches and monetizes new apps in less than one month. The company capitalizes on Gen Z’s demand for apps that deliver quick but meaningful and fun interactions, with apps like Litstick, which offers short, engaging content in the form of prank stickers.

This round of funding from Braavo Capital positions Sociaaal for further expansion, with the goal of doubling their size within the next year. The company also has plans to expand beyond social and entertainment apps into new categories like self-improvement, productivity, and wellbeing, already demonstrated by products like its AI-powered Dreamwise app that allows users to record and analyze their dreams.

“We are impressed with Sociaaal’s growth and are thrilled to lead this financing round,” says Mark Loranger, CEO of Braavo Capital. “Braavo’s $4 million commitment demonstrates our belief in their team’s vision and ability to execute.”

Sociaaal CEO Patrick Stuart-Constant reiterated the sentiment, “Braavo has been an invaluable partner throughout Sociaaal’s growth journey, and was a natural fit for this round of financing. Their ability to quickly understand Sociaaal’s growth potential made them an ideal partner for this critical phase of expansion.”

About Sociaaal

Founded in 2022, Sociaaal is the fast-growing mobile app studio that specializes in building, buying, and publishing non-gaming apps for Gen Z . The company has leveraged its expertise in rapid iteration, AI, and data driven strategies to reach over 34 million installs across its portfolio of 20 apps.

About Braavo Capital

Established in 2015, Braavo is the leading funding partner for the world’s most successful app businesses. Having facilitated over $1 billion in financing and supported over 8000 apps since inception, Braavo offers a range of financing, from on-demand receivables to multi-million dollar bespoke credit facilities.

SOURCE Sociaaal

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Mindful Venture Capital Closes $5 Million First Fund

MENLO PARK, Calif., Oct. 23, 2024 — Mindful Venture Capital (Mindful VC), a Silicon Valley-based early-stage venture capital firm powered by behavior design that backs mindful entrepreneurs building the future through technology, closed $5 million for its first fund in December 2022.

The power of behavior design goes beyond its application of insights from science and industry operators to company building and venture capital investment with its core thesis that behavior design can be used to invest better in venture capital markets.

Within two years, the firm made over fifteen investments into eleven companies, of which over 40% were follow-on investments priced by external lead investors.

RAND corporation is reporting that “more than 80% of AI projects fail” and McKinsey is sharing that over 90% of artificial intelligence (AI) pilots fail before making it to a proof of concept (POC), especially in AI, natural language processing (NLP), and machine learning (ML).

Mindful VC’s trending success rate of companies progressing beyond proof of concept (POC) is over 70% with over 25% progressing to Series A since initial funding.

“We are innovators of behavior design investing using a systematic analysis that builds on top of traditional fundamental and quantitative analyses to move us into this next generation of mindful analysis,” said Ari Qayumi, Founder, General and Managing Partner of Mindful VC.

“We invest in people building tools that analyze and augment positive, diverse human abilities. We look for intentionality in the team, product, and business model. From persuasive to consensual to mindful computing, we back companies building mindful ventures and continue to back those that we believe are already in, or have the potential to achieve entry into, the mindful technologies category.”

Mindful VC invests in companies pioneering the next generation of innovation and intelligence that are advancing the health and performance of humans, machines, and environments. On a per fund deal basis, as in Mindful VC’s first fund, the firm targets 90% based in the United States and up to 10% elsewhere.

About Mindful VC
Mindful VC is a Silicon Valley-based early-stage venture capital firm powered by Behavior Design that backs mindful entrepreneurs building the future through technology.

SOURCE Mindful Venture Capital

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Validation Cloud si assicura un investimento principale di 10 milioni di dollari da True Global Ventures per adeguare l’IA per Web3

ZUG, Svizzera, 23 ottobre 2024 — Validation Cloud, azienda leader nel settore dei dati Web3 e dell’IA, ha selezionato True Global Ventures come suo investitore principale, con un contributo di 10 milioni di dollari. L’azienda prevede di utilizzare i fondi per espandere il suo prodotto di intelligenza artificiale, offrendo un accesso fluido ai dati Web3 e consentendo esperienze utente senza pari agli ecosistemi e alle applicazioni di rete.

“Web3 ha bisogno di un accesso senza problemi ai dati per raggiungere un miliardo di utenti; Validation Cloud sta risolvendo questo ostacolo critico per l’adozione grazie a innovazioni tecnologiche nella sua piattaforma principale insieme all’intelligenza artificiale. Abbiamo visto servizi di staking e API di nodi, ma mai in combinazione con l’intelligenza artificiale. Questo è ciò che ci entusiasma di più dell’offerta di prodotti dati di Validation Cloud per le aziende di infrastrutture Web3″, ha affermato Beatrice Lion, CEO e General Partner di True Global Ventures.

La piattaforma di prodotti dell’azienda comprende tre componenti: staking, API dei nodi, dati e IA. Per quanto riguarda lo staking, Validation Cloud ha superato il valore di 1 miliardo di dollari di asset in staking, con una crescita del 400% su base annua. Inoltre, la sua Node API registra costantemente le migliori prestazioni globali, misurate da CompareNodes. Tra i clienti di Validation Cloud figurano Chainlink, Aptos, Consensys, Stellar e Hedera.

In particolare, la sua piattaforma di intelligenza artificiale semplifica e accelera l’esplorazione dei dati on-chain. Comprimendo i tempi di navigazione da ore a secondi, la piattaforma di Validation Cloud favorisce un maggiore coinvolgimento, con la conseguente creazione di una base di utenti più ampia e attiva. Questa innovazione rappresenta uno sviluppo decisivo nel rendere i dati blockchain più accessibili.

“Siamo entusiasti di collaborare con True Global Ventures vista la sua portata commerciale globale, l’attenzione all’intersezione tra Web3 e IA e il suo portafoglio sinergico. TGV presenta un profondo legame con la nostra missione e un valore aggiunto eccezionale che va oltre il suo capitale”, ha affermato Alex Nwaka, co-fondatore di Validation Cloud.

Validation Cloud è una delle aziende in più rapida crescita nel settore del Web3. Questo round di finanziamento segue la raccolta fondi della società avvenuta nel  febbraio 2024, guidata da Cadenza Ventures con sede a San Francisco, con la partecipazione di Blockwall, Bloccelerate, Side Door Ventures, GS Futures, AP Capital, Blockchain Founders Fund e Metamatic.

Informazioni su Validation Cloud

Validation Cloud  è un’azienda di dati e intelligenza artificiale Web3 con prodotti leader del settore in termini di staking, nodi e Data-as-a-Service. Validation Cloud è la scelta di riferimento delle principali reti, applicazioni e aziende in ambito Web3 che richiedono massime prestazioni, scalabilità e conformità SOC 2 Tipo 2.

Ulteriori informazioni sono disponibili su Validationcloud.io | LinkedIn | X  | Podcast

Per richieste di informazioni da parte degli investitori, contattare: [email protected] 

Informazioni su True Global Ventures, TGV

Il fondo TGV 4 Plus investe in aziende basate sull’intelligenza artificiale e sulla blockchain a livello globale. TGV sostiene imprenditori lungimiranti in settori quali l’IA, l’intrattenimento, le infrastrutture tecnologiche e i servizi finanziari nelle fasi iniziali e oltre la Serie B.

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

U.S. Sodium-Ion Battery Startup Receives Investment from LG Technology Ventures

  • UNIGRID Inc., a California-based startup that develops advanced sodium-ion batteries, announces that it has received an investment from LG Technology Ventures.
  • This investment is part of LG Technology Ventures’ dedication to creating value in promising startup companies and helping them develop strategic partnerships with LG Companies.

SAN DIEGO, Oct. 22, 2024 — LG Technology Ventures, has made an investment in UNIGRID Inc., a California-based startup that develops advanced sodium-ion batteries, placing a stake in the emerging sodium ion battery development space.

LG Technology Ventures’ investment in UNIGRID reflects a thorough technical evaluation, serving as an endorsement of the startup’s innovative sodium-ion battery technology. This support from one of the market leaders not only accelerates UNIGRID’s growth but also signals to the market the robustness and potential of their solutions.

Sodium-ion batteries are produced using abundant sodium-based materials. UNIGRID’s batteries do not contain lithium, nickel, cobalt, nor copper, offering a promising pathway to mitigating the supply chain risks of lithium-based batteries. Sodium-ion batteries are applicable for a versatile array of energy storage applications as they are less expensive, safer, and can operate over a wide temperature range.

Since its inception, UNIGRID has positioned itself as a sodium-ion innovator and a technology frontrunner, developing cells with energy densities that exceed lithium iron phosphate (LFP) batteries. Additionally, the sodium ion battery technology offers safety properties that are superior to conventional batteries.

UNIGRID is currently in the midst of ramping up production to meet immediate customer demands. This new financing will help the company accelerate its product commercialization and build upon existing industry partnerships to deploy its technology for new energy storage and e-mobility applications.

About UNIGRID Battery

UNIGRID Battery, a University of California, San Diego spin-off company, was founded in 2021 from the groundbreaking Ph.D. research work by Dr. Darren H. S. Tan and Dr. Erik A. Wu, who were both advised by Prof. Zheng Chen and Prof. Shirley Meng, prominent figures in the battery field. The company develops advanced sodium-ion batteries to power both emerging energy storage and electric mobility applications.

Visit unigridbattery.com or follow UNIGRID Battery on Linkedin for more information.

SOURCE UNIGRID Battery

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Validation Cloud haalt 10 miljoen dollar binnen van True Global Ventures om AI voor Web3 op te schalen

ZUG, Zwitserland, 23 oktober 2024 — Validation Cloud, het toonaangevende Web3-data en AI-bedrijf, heeft True Global Ventures geselecteerd als hoofdinvesteerder, met een bijdrage van 10 miljoen dollar. Het bedrijf is van plan de fondsen te gebruiken om zijn AI-product uit te breiden, om naadloze toegang tot Web3-data en ongeëvenaarde gebruikerservaringen met netwerkecosystemen en -toepassingen te leveren.

“Web3 heeft naadloze toegang tot data nodig om een miljard gebruikers te bereiken. Validation Cloud lost deze kritieke hindernis voor adoptie op met technologische doorbraken in zijn kernplatform naast AI. We hebben staking en node API-diensten gezien, maar nooit in combinatie met AI. Het is juist deze combinatie die wij zo spannend vinden in de dataproducten die Validation Cloud voor bedrijven met Web3-infrastructuur aanbiedt,” zegt Beatrice Lion, CEO & General Partner van True Global Ventures.

Het productplatform van het bedrijf bestaat uit drie componenten: staking, node API en data & AI. Op het gebied van staking heeft Validation Cloud meer dan 1 miljard dollar aan assets gestaked, met een groei van 400% op jaarbasis. Bovendien laat de Node API consistent de beste globale prestaties zien, gemeten door CompareNodes. Validation Cloud heeft onder meer als klanten Chainlink, Aptos, Consensys, Stellar en Hedera.

Vooral het AI-platform maakt het verkennen van gegevens op de keten eenvoudiger en sneller. Door navigatie te comprimeren van uren naar seconden, zorgt het platform van Validation Cloud voor een grotere betrokkenheid, waardooer het gebruikersbestand groter en actiever wordt. Deze innovatie maakt het verschil in het toegankelijker maken van blockchaingegevens.

“We zijn enthousiast om samen te werken met True Global Ventures vanwege zijn wereldwijde commerciële bereik, focus op het snijvlak van Web3 en AI, en zijn synergetische portfolio. TGV sluit nauw aan bij onze missie en heeft een uitzonderlijke toegevoegde waarde die verder gaat dan zijn kapitaal,” zegt Alex Nwaka, medeoprichter van Validation Cloud.

Validation Cloud is een van de snelst groeiende bedrijven in Web3. Deze financieringsronde volgt op de verhoging van het bedrijf in februari 2024, geleid door het in San Francisco gevestigde Cadenza Ventures, met deelname van Blockwall, Bloccelerate, Side Door Ventures, GS Futures, AP Capital, Blockchain Founders Fund en Metamatic.

Over Validation Cloud

Validation Cloud is een Web 3-data- en AI-bedrijf met toonaangevende producten op het gebied van staking, node en data-as-a-service. Validation Cloud wordt vertrouwd door de topnetwerken, -toepassingen en -ondernemingen in Web3 die de hoogste eisen stellen aan prestaties, schaalbaarheid en SOC2 type 2-compliance.

Meer informatie op Validationcloud.io | LinkedIn | X  | Podcast

Voor investeerdersvragen kunt u contact opnemen met: [email protected] 

Over True Global Ventures, TGV

TGV 4 Plus Fund investeert wereldwijd in AI- en blockchainbedrijven. TGV steunt visionaire ondernemers in sectoren zoals AI, entertainment, technologische infrastructuur en financiële diensten in vroege stadia en na de Serie B.

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In